Skip to content

Kura Oncology KURA Investment Purchases

Investment Purchases at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$144M-42.6%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$39.39M+274%
Corvus Pharmaceuticals logo
Corvus PharmaceuticalsCRVS
$161.74M+1,998%
Cullinan Therapeutics, Inc. logo
Cullinan Therapeutics, Inc.CGEM
$20.14M-84.0%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$5.87M-74.6%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$2.51B+52.2%

Other financials

Income statement

See full
Revenue$18.3M+29.5%
Gross profit$18.0M
Operating income-$78.8M-21.8%
Net income-$73.3M-27.7%
EPS (diluted)-$0.83-25.8%

Balance sheet

See full
Cash & equivalents$39.1M-23.8%
Total debt$24.3M+25.4%
Total equity$107.9M-70.4%
Total assets$652.6M-12.3%

Cash flow

See full
Operating cash flow-$85.9M-19.4%
CapEx$128.0K-56.2%
Free cash flow-$86.0M-19.1%

Valuation

See full
Market cap$919.7M+81.6%
Enterprise value$904.89M+90.7%
P/S12.8×+3.5×

Profitability

See full
Operating margin-443.5%+103pp
Net margin-411.2%+125pp
FCF margin130.6%+74.1pp

Returns & leverage

See full
Return on equity-124.7%-252pp
Debt / equity0.2×+0.2×
Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireShortTermInvestments.

The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kura Oncology's investment purchases?
Kura Oncology (KURA) reported investment purchases of $171.6M in Q1 2026.
How has Kura Oncology's investment purchases changed year-over-year?
Kura Oncology's investment purchases decreased by 36.1% year-over-year, from $268.71M to $171.6M.
What is the long-term trend for Kura Oncology's investment purchases?
Over 3 years (2022 to 2025), Kura Oncology's investment purchases has grown at a 41.2% compound annual growth rate (CAGR), from $270.66M to $761.59M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.